Dietary Recommendations for Dysgeusia and Anosmia
For patients with taste and smell alterations, recommend olfactory training as the primary intervention, combined with flavor enhancement strategies, individualized dietary counseling focusing on texture and temperature variations, and consideration of zinc supplementation (150mg, 2-3 times daily) particularly in those undergoing cancer treatment or with documented deficiency.
Evidence-Based Approach
Primary Intervention: Olfactory Training
The most recent guideline evidence indicates that olfactory training should be suggested for all patients with smell disturbances due to its simplicity and safety profile 1. While the ESCMID 2022 guidelines note insufficient evidence for most interventions in post-COVID smell/taste disturbances, they specifically endorse olfactory training as a low-risk option that demonstrated benefit across 11 studies evaluating postinfectious olfactory dysfunction 1.
Dietary Modifications and Counseling
Patients with chemosensory dysfunction require specific dietary adaptations to prevent malnutrition:
Flavor enhancement techniques: Use stronger seasonings, herbs, and spices to compensate for diminished taste perception 2, 3. Research shows 39% of patients with olfactory loss naturally increase spice use 4.
Texture and temperature variations: Modify food consistency and serve foods at varying temperatures to enhance sensory experience and maintain interest in eating 3.
Protein and dairy emphasis: Patients with dysosmia show reduced intake of protein and dairy products 5, so actively encourage high-protein foods, dairy products, and protein supplementation to prevent sarcopenia and malnutrition 6.
Avoid reliance on sweet foods: Patients commonly shift toward savory and salty foods while reducing sweets and sweet beverages 4. Support this natural adaptation rather than forcing sweet items.
Zinc Supplementation Considerations
For cancer patients undergoing chemotherapy or radiotherapy, zinc supplementation (150mg, 2-3 times daily) may prevent and ameliorate treatment-induced dysgeusia and mucositis 2. However, this recommendation is primarily supported in the oncology context. The evidence is mixed: zinc showed benefit in one retrospective study and one RCT for chemotherapy/radiotherapy-induced taste changes 2, but normal zinc levels don't exclude dysgeusia 6.
Nutritional Monitoring
Implement systematic monitoring to prevent malnutrition:
- Monthly weight checks, as 29% of patients with olfactory loss eat less overall 4
- Track protein-energy intake specifically
- Screen for early satiety and reduced meal frequency
- Monitor for both undernutrition and overnutrition risk (COVID-19 anosmia increases overnutrition risk, OR 1.36) 7
Clinical Pitfalls to Avoid
Do not assume zinc deficiency is the cause - patients can have severe dysgeusia with normal zinc levels 6. Supplementation may still help in specific contexts (cancer treatment) but isn't universally indicated.
Do not delay nutritional intervention - early dietary counseling and nutritional support prevent significant weight loss. In one study, early nutritional management reduced the proportion of patients with >5% weight loss from 54% to 38% 8.
Do not overlook medication review - certain medications (like mycophenolate mofetil) can trigger or worsen dysgeusia 6. Review the medication list for potential contributors.
Recognize spontaneous recovery potential - particularly in post-viral cases, discuss the likelihood of spontaneous improvement with patients while implementing supportive measures 1. This prevents unnecessary aggressive interventions while maintaining realistic expectations.
Additional Considerations
Smoking cessation should be recommended for overall health benefits, though its specific benefit for chemosensory dysfunction remains unclear 1. Other interventions including intranasal corticosteroids, theophylline, and insulin nasal spray have limited or conflicting evidence and should only be considered within clinical trials 1.
The combination of taste/smell training with personalized dietary counseling and flavor enhancement demonstrated clinically significant benefit in one prospective pilot trial and one RCT 2, making this the most evidence-supported comprehensive approach.